These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 18846027

  • 1. Amiodarone-induced thyrotoxicosis. A review.
    Piga M, Serra A, Boi F, Tanda ML, Martino E, Mariotti S.
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [Abstract] [Full Text] [Related]

  • 2. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
    Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, Ceccarelli C, Pinchera A, Bartalena L, Braverman LE.
    J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
    [Abstract] [Full Text] [Related]

  • 3. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [Abstract] [Full Text] [Related]

  • 4. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E.
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [Abstract] [Full Text] [Related]

  • 5. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S.
    Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
    [Abstract] [Full Text] [Related]

  • 6. Amiodarone and thyroid dysfunction.
    Padmanabhan H.
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [Abstract] [Full Text] [Related]

  • 7. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G, Filus A, Kuliczkowska J, Bugajski J.
    Postepy Hig Med Dosw (Online); 2004 Apr 20; 58():216-25. PubMed ID: 15114257
    [Abstract] [Full Text] [Related]

  • 8. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
    Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda ML, Miccoli P, Basolo F, Pinchera A, Bartalena L, Braverman LE, Martino E.
    J Endocrinol Invest; 2002 Feb 20; 25(2):176-80. PubMed ID: 11929091
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
    Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E.
    Clin Endocrinol (Oxf); 2004 Oct 20; 61(4):494-502. PubMed ID: 15473883
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis.
    Wang J, Zhang R.
    Br J Radiol; 2017 Mar 20; 90(1071):20160836. PubMed ID: 28106465
    [Abstract] [Full Text] [Related]

  • 11. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM.
    Clin Endocrinol (Oxf); 2006 Oct 20; 65(4):433-8. PubMed ID: 16984234
    [Abstract] [Full Text] [Related]

  • 12. Amiodarone and the thyroid.
    Jabrocka-Hybel A, Bednarczuk T, Bartalena L, Pach D, Ruchała M, Kamiński G, Kostecka-Matyja M, Hubalewska-Dydejczyk A.
    Endokrynol Pol; 2015 Oct 20; 66(2):176-86. PubMed ID: 25931048
    [Abstract] [Full Text] [Related]

  • 13. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M, Perra E, Melis A, Cianchetti ME, Piga M, Serra A, Pinna G, Mariotti S.
    Acta Radiol; 2007 Jul 20; 48(6):628-34. PubMed ID: 17611870
    [Abstract] [Full Text] [Related]

  • 14. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E.
    J Clin Endocrinol Metab; 1994 Feb 20; 78(2):423-7. PubMed ID: 8106631
    [Abstract] [Full Text] [Related]

  • 15. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
    Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E.
    Clin Endocrinol (Oxf); 2007 Oct 20; 67(4):533-7. PubMed ID: 17561980
    [Abstract] [Full Text] [Related]

  • 16. [Amiodarone treatment and thyroid disorders].
    Łacka K, Fraczek MM.
    Pol Merkur Lekarski; 2013 Jul 20; 35(205):5-9. PubMed ID: 23984597
    [Abstract] [Full Text] [Related]

  • 17. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R, Fica S, Barbu C, Vârtej I, Ursu H, Bunghez R, Coculescu M.
    Rom J Intern Med; 2004 Jul 20; 42(3):595-605. PubMed ID: 16366133
    [Abstract] [Full Text] [Related]

  • 18. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis.
    Gursoy A, Tutuncu NB, Gencoglu A, Anil C, Demirer AN, Demirag NG.
    J Natl Med Assoc; 2008 Jun 20; 100(6):716-9. PubMed ID: 18595575
    [Abstract] [Full Text] [Related]

  • 19. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
    Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E.
    J Clin Endocrinol Metab; 1996 Aug 20; 81(8):2930-3. PubMed ID: 8768854
    [Abstract] [Full Text] [Related]

  • 20. The effects of amiodarone on the thyroid.
    Martino E, Bartalena L, Bogazzi F, Braverman LE.
    Endocr Rev; 2001 Apr 20; 22(2):240-54. PubMed ID: 11294826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.